A Form 4 filed on August 31, 2026 disclosed that Stephen Hoge, President of Moderna, Inc. (NASDAQ:MRNA), reported restricted stock unit vestings and related share withholdings for tax obligations on August 27 and August 28, 2026.
Key Highlights
- RSU vesting on August 27, 2026: 1,437 restricted stock units converted into common stock on a one-for-one basis.
- Shares withheld on August 27, 2026: 695 shares were withheld at a price of $149.66 per share to satisfy tax withholding obligations.
- RSU vesting on August 28, 2026: 611 restricted stock units converted into common stock on a one-for-one basis.
- Shares withheld on August 28, 2026: 296 shares were withheld at a price of $142.77 per share to satisfy tax withholding obligations.
- Direct beneficial ownership following transactions: 1,484,905 shares of common stock held directly.
- Indirect ownership: 4,116 shares held indirectly by Valhalla, LLC and 151,933 shares held indirectly by a trust for the benefit of Hoge's spouse and children.
Moderna President Reports RSU Vestings and Tax-Related Share Withholdings
According to the Form 4 filed with the SEC on August 31, 2026, Stephen Hoge, serving as President of Moderna, Inc., reported two separate restricted stock unit vesting events. On August 27, 2026, 1,437 RSUs converted into common stock on a one-for-one basis, followed by 695 shares withheld at $149.66 per share to cover tax withholding obligations. Following these transactions, Hoge's direct beneficial ownership stood at 1,484,590 shares, according to the filing.
On August 28, 2026, the filing disclosed a second vesting event in which 611 RSUs converted into common stock. Subsequently, 296 shares were withheld at $142.77 per share for tax withholding purposes, leaving Hoge with 1,484,905 shares of common stock held directly. The filing attributed the share withholdings to Hoge's election to satisfy tax obligations in connection with the RSU vestings.
The filing also noted that remaining RSU balances following these transactions were 8,621 units under one award and 1,221 units under a second award, both held directly. Regarding the vesting schedule of the first award, the filing stated that 25% vested on February 27, 2025, with the remainder vesting in twelve equal quarterly installments thereafter. For the second award, 25% vested on February 28, 2024, with the remainder vesting in twelve equal quarterly installments thereafter. The 151,933 shares held indirectly through a trust are for the benefit of Hoge's spouse and children, and the filing noted that Hoge "disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any."
What Was Disclosed
The filing reported two RSU vesting events for Moderna President Stephen Hoge on August 27 and 28, 2026, with shares withheld for tax purposes at $149.66 and $142.77 respectively. Direct beneficial ownership following all transactions was reported as 1,484,905 shares.



Please wait processing your request...